Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials - Vale, Claire L; Fisher, David J; Godolphin, Peter J; Rydzewska, Larysa H; Boher, Jean-Marie; Burdett, Sarah; Chen, Yu-Hui; Clarke, Noel W; Fizazi, Karim; Gravis, Gwenaelle; James, Nicholas D; Liu, Glenn; et al. (The lancet oncology, 2023)
Keywords: Androgen Antagonists; Androgens; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Cancer therapies; Chemotherapy; Clinical trials; Decision making; Disease-Free Survival; Docetaxel; Endocrine therapy; Hematology, Oncology, and Palliative Medicine; Hormones - therapeutic use; Humans; Male; Medical diagnosis; Medical prognosis; Medical research; Meta-analysis; Metastases; Metastasis; Patients; Prostate cancer; Prostatic Neoplasms - pathology; Randomized Controlled Trials as Topic; Sensitivity analysis; Survival; Systematic review